In this study, in which we investigated the clinical and hematological differences between mutation-positive ET and triple-negative ET, it was observed that patients with triple-negative ET had a significant female predominance, and patients with JAK2, CALR, or MPL mutations were diagnosed at an older age. This evidence concerns the gene JAK2 and essential thrombocythemia.